Literature DB >> 22873542

Lenalidomide for multiple myeloma.

Francesco Bertolini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22873542     DOI： 10.1056/NEJMc1206734

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity.

Authors:  Sinto Sebastian; Yuan X Zhu; Esteban Braggio; Chang-Xin Shi; Sonali C Panchabhai; Scott A Van Wier; Greg J Ahmann; Marta Chesi; P Leif Bergsagel; A Keith Stewart; Rafael Fonseca
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

2.  Integration of Different "-omics" Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells.

Authors:  Benjamin Wiench; Yet-Ran Chen; Malte Paulsen; Rebecca Hamm; Sven Schröder; Ning-Sun Yang; Thomas Efferth
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-19       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.